Synthetic Biology Market Size, Share, Report 2026 To 2035

Synthetic Biology Market Size, Growth, Forecast 2026 to 2035

The global synthetic biology market size was valued at USD 19.03 billion in 2025 and is expected to be worth around USD 64.50 billion by 2035, reflecting a compound annual growth rate (CAGR) of 12.98% during the forecast period 2026 to 2035. The U.S. synthetic biology market size was estimated at USD 5.93 billion in 2025. The synthetic biology market is expanding rapidly due to advancements in genetic engineering and increasing demand for sustainable solutions. Innovations in CRISPR gene-editing technology, synthetic DNA synthesis, and AI-driven bioengineering are fueling industry growth.

Governments and private sectors are investing heavily in research, further accelerating developments in healthcare, biofuels, and industrial biotechnology. Additionally, growing awareness of sustainable alternatives in food production, such as lab-grown meat and plant-based proteins, is driving adoption. The pharmaceutical sector is leveraging synthetic biology for vaccine development and gene therapies. As industries recognize the potential of engineered organisms, synthetic biology is expected to revolutionize multiple sectors, making it a crucial player in the future of biotechnology.

What is a Synthetic Biology?

Synthetic biology is an advanced field of science that combines biology, engineering, and computer science to design and build new biological systems. Scientists modify or create DNA sequences to develop organisms with specific traits, such as bacteria that produce biofuels or crops with improved resistance to pests. This approach enables innovations in medicine, agriculture, and environmental conservation. One key application is in healthcare, where synthetic biology helps in developing personalized medicine and synthetic insulin. In agriculture, it enhances crop yields and reduces the need for chemical fertilizers. Additionally, synthetic biology is used to create biodegradable plastics, reducing environmental pollution. This field continues to evolve, unlocking solutions for global challenges like climate change, food security, and disease prevention.

Key insights beneficial to the synthetic biology market:

• Increase in Research Investment: Global R&D funding in synthetic biology has grown by over 30% annually in the past decade.
• Biotechnology Industry Expansion: Synthetic biology contributes to over 15% of biotech industry innovations.
• Healthcare Advancements: Over 50 new synthetic biology-based therapies are in development for diseases like cancer and genetic disorders.
• Agricultural Benefits: Genetically engineered crops using synthetic biology techniques have improved crop yield by 20-30%.
• Sustainability Impact: Synthetic biology-based materials are reducing carbon emissions by up to 40% compared to traditional manufacturing.
• Startups & Investments: More than USD 10 billion has been invested in synthetic biology startups in recent years, signaling strong market potential.

Report Highlights

• By Region, North America dominates the synthetic biology market, accounting for around 41.58% revenue share in 2025, driven by strong R&D investments, advanced biotechnology infrastructure, and a high concentration of leading industry players. 
• By Region, Europe holds a significant position, capturing approximately 27.52% revenue share in 2025, supported by favorable government initiatives, funding programs, and growing focus on sustainable bio-based solutions. 
• By Technology, the NGS (next-generation sequencing) technology segment leads the market with around 30.10% share in 2025, owing to its critical role in genome analysis, genetic engineering, and accelerating synthetic biology research processes. 
• By Product, the oligonucleotide/oligo pools and synthetic DNA segment dominates the market, accounting for nearly 35.47% revenue share in 2025, driven by its essential use in gene synthesis, diagnostics, and advanced therapeutic development. 
• By Application, the healthcare segment holds the largest share, capturing approximately 56.97% revenue in 2025, primarily due to increasing adoption in gene therapy, vaccine development, and personalized medicine. 
• By End User, the biotechnology and pharmaceutical companies segment leads the market with around 51.80% revenue share in 2025, supported by extensive use of synthetic biology in drug discovery and biopharmaceutical production. 
• By End User, the academic and research institutes segment is expected to witness strong growth during the forecast period, driven by rising research activities, government funding, and increasing collaborations in synthetic biology innovation. 

Regulatory Landscape and Government Initiatives

Synthetic Biology Market Growth Factors

• Rising Demand for Sustainable Solutions: The synthetic biology offers viable and sustainable solution in various sectors such as agriculture, energy and materials. The production of the biofuels, bioplastics, and genetically engineered crops becomes easier with the help of synthetic biology as it reduces the environmental impact. The consumer desire for eco-friendly products has swelled excessively making the companies utilize synthetic biology for their survival in the market. Particularly, bioengineered solutions save greenhouse gas emissions and resource usage in comparison with conventional methods.
• Advancements in Genetic Engineering Tools: The recent and most effective tools such as CRISPR-Cas9, TALENs, and DNA synthesis technologies make genetic editing the path of the revolution. These tools make cries for precision of DNA manipulation, enabling the production of systems and processes, controlling the DNA. The dropping costs of genetic sequencing and editing further lightened the road of innovation in this field of research, making it accessible to more and more researchers and companies.
• Applications in Personalized Medicine: Synthetic biology is of great importance in the development of personalized medicine as it is the key to the achievement of gene therapies, engineering of immune cells, and targeting drug delivery systems. The soaring number of genetic disorders and chronic diseases makes healthcare providers search for tailored solutions to elevate the patient outcomes level. Synthetic biology technologies including CAR-T cell therapy for cancer which are helping death prognosis, are the key to this transformation.
• Increasing Application in Agriculture Biotechnology: Enhanced synthetic biology in agricultural sector has many useful applications such as modification of plants to create crops that are tolerant to pests, diseases and even climate shakes. It also allows the creation of biofertilizers and other microbial agents that enhance soil and crop productivity. These technological advancements are very helpful considering the current population growth and climate change that threaten the food supply of the world.
• Bio-Manufacturing of Industrial Products: Within the area of synthetic biology, products, i.e. chemicals, drugs, materials can be produced in a bio-based way without the intervention of fossil fuel based technologies. Thus, the technologies developed are eco-friendly and cheaper, for example instead of using fossil fuels to produce their raw materials for blown plastic bags and chemical dressings called isoprene in rubber, where biosynthesis comes in handy. Biomanufacturing techniques are highly modular and low-energy prompting high level of interest and funding from companies looking for a sustainable solution.

Synthetic Biology Market Recent Trends

• Government and Private Investments: The synthetic biology sectors has seen a tremendous inflow of cash not only from the public sector but also from the private sector. The USA National Synthetic Biology Initiative and Horizon Europe Programs are some of the initiatives aimed at improving research in synthetic biology, as well as its commercialization. Such funding fosters development of businesses, research as well as educational institutions that seek to come up with new ideas and solutions. In addition, the industrialists join hands with the government to create a conducive environment in which the market will thrive.
• Advances in Artificial Intelligence Integration: Synthetic biology is undergoing a paradigm shift, with the application of artificial intelligence simplifying the modelling, simulation, and optimization processes of genetic circuits and metabolic pathways. The emergence of AI tools has rendered the traditional design-build-test-learn approach much cheaper and faster in synthetic biology R&D. For instance, AI can ascertain the functional characteristics of a synthetic organism in the given context or redesign a pathway within a microbe to obtain the greatest amount of product.
• Increased Emphasis on Renewable Sources of Energy: Algal biofuel is an energy product derived as a result of the incorporation of synthetic biology in the fields of renewable energy. Bioengineered microorganisms can rapidly generate biofuels from feedstock biomass and thus come in handy in mitigating fossil fuels reliance as well as its carbon footprint. Even an energy producing system of algae is capable of bios orbing carbon while producing energy, which is a current dilemma for climate change.
• Increased Adoption in Environmental Solutions: The synthetic biology solves the environmental challenges with the usage in bioremediation, carbon capture and the pollution control. The genetically modified microorganisms can reduce the pollutants, clean up oil spills, and absorb heavy metals from the contaminated sites. All these methods are faster and more environmentally friendly than the traditional methods of cleaning the environment.
• Expanding Synthetic Food Production: There is a huge boom in the area of food production thanks to synthetic biology especially where innovation like cultured meat and meat alternatives comes in. These solutions alleviate the problems of animal farming and its ecologically destructive practices without sacrificing the consumers’ desire for better food. In one case, for instance, as synthetic biology helps in the production of the lab-grown meat having the same taste & texture as the conventional meat along with reducing the usage of land and water.

Report Scope

Synthetic Biology Market Dynamics

Drivers

Expanding Synthetic Food Production

• Synthetic biology is changing the narrative of food production through examples such as cultured meat and its plant-based counterparts. These non-animal-based products address the ethical issues that arise from rearing animals and its effects on climate while satisfying the desire of meat eaters to consume environmentally healthy foods. For instance, lab grown meat which utilizes techniques of synthetic biology is able to replicate the taste and texture of meat without the land and water practices involved in livestock rearing. The growing interest of consumers in alternative proteins is one of the reasons for the integration of synthetic biology in the food sector.

Reduction in DNA Sequencing and Synthetic Costs

• With the inventions of less expensive equipment and more efficient processes, DNA sequencing and synthesis costs have become within the reach of everyone with enough respect for synthetic biology. Such low pricing style creates a market for innovativeness where even new entrepreneurship and small research institutions can afford to play. As the sayings goes the lower the cost the easier the development and the faster the returns, cost cuts also shorten the r and d periods enabling the companies to rush the products to the market. Gradually as prices become lower, it is expected that synthetic biology will be cheaper than a current price level and therefore its propagation will be intense.

Restraints

Ethical Concerns and Public Perception

• Intrinsic aspects of genetic alterations such as the risk of abuse of gene manipulation and long-term ecological consequences impede market development. Public reluctance towards ‘biological Gods’ creates resistance, hence elongating the rate of acceptance. These apprehensions have to be forestalled through the use of ethical measures and engagements to ensure public confidence and enable the growth of the market.

Regulatory and Safety Challenges

• The absence of appropriate measures in relation to syntactic biology implies lack of confidence for the enterprises and thus discourages the use of the products. Approval of applications that involve the use of synthetic biology within the regulated industries is also undertaken with some degree of reluctance on the part of the regulators as a result of the potential risks to safety. This can lead to extended delays in the commercialization of products and result in increased costs of doing business, particularly compliance costs, and therefore acts as a barrier to the growth of the market.

Opportunities

Rapid Growth in the Biotechnology Sector

• Enhancement in the working of biotechnology sector encourages the use of synthetic biology. Biotech firms are investing greatly in synthetic biology for building the new age therapies, agricultural interventions, and industrial uses. The growth of the sector encourages invention, establishment of infrastructure, and recruitment of personnel to further the growth of synthetic biology techniques so as to keep pace with the market demand.

Adoption in the Cosmetics Industry

• It is very common today to find use of synthetic biology in the production of organic active cosmetic ingredients, which are eco-friendlier and safer than the conventional chemicals. For instance, without the use of shark liver oil scientists have found a way of employing engineered bacteria that can produce squalene, a moisturizing agent in high demand. The growth in the adoption as well as the sale of natural and organic cosmetics in the market is a factor affecting the growth of synthetic biology in the applications of the cosmetics industry thereby opening up new profitable markets for the technology.

Challenges

Excessive Costs for Research and Development

• The cost of establishing R&D in synthetic biology is generally exceedingly high, especially for young companies and small businesses. The expenses of purchasing state-of-the-art equipment, running tests, and following up with legal requirements are often high. These financial constraints inhibit the growth of new entrants in the industry causing them to limit competition and stifle innovation.

Potential Threats to the Environment

• The utilization of synthetic organisms possess inherent risk in their introduction into the ecosystem, which is highly likely to lead to adverse effects such as crossbreeding of modified genes with native species and interference with the existing species. Such risks have made the use of these technologies attract laws for instance the calling for more stringent regulations which would be against the progression of these synthetic biology technologies.

Synthetic Biology Market Regional Analysis

Why does North America dominates the synthetic biology market?

The North America synthetic biology market size was estimated at USD 7.91 billion in 2025 and is expected to reach around USD 26.82 billion by 2035. The region dominates the market thanks to a high level of R&D expenditure, development of relevant infrastructure, and existence of a thriving biotechnology market. Within this region, the U.S. holds the highest rank owing to its innovations in health care, agricultural biotechnology, and industrial bio-manufacturing.

U.S. Synthetic Biology Market Trends

• The United States occupies a dominant share of the synthetic biology market because of the presence of sophisticated biotechnology infrastructure, investments and spending on R&D activities and number of top players of synthetic biology. 
• The United States holds a leading position due to its highly developed genomics capabilities, matured venture capital (VC) industry and effective collaboration among university, pharmaceutical companies and biotech start ups.
• U.S. biotechnology industry is able to secure investment and to support the growth of synthetic biology in several sectors of the industry such as healthcare, agriculture, food technology, industrial application. U.S. synthetic biology sector has raised billions of investment as venture capital which is helping in developing Engineered organisms, Synthetic DNA, Bio based manufacturing platform.
• Healthcare has accounted for the largest segment for synthetic biology in the U.S. with the increased focus in gene and cell therapy and personalized medicine. Approval of various advance therapy and the growth of genomic medicine are also fueling the market demand of the tools and application used in synthetic biology, therapeutic development, drug discovery, and biological engineering.
• U.S. market of synthetic biology is showing growth in the bio manufacturing and alternative application which help in achieving sustainability. These application use engineered microorganisms which help in manufacturing chemicals, fuels, materials, ingredients with comparatively lower effect on the environment compared to other conventional manufacturing methods.

Why Europe hits notable growth in the synthetic biology market?

The Europe synthetic biology market size was accounted for USD 5.24 billion in 2025 and is projected to hit around USD 17.75 billion by 2035. Europe is also a major region, standing out from others with a range of supportive policies and funding opportunities such as Horizon Europe. It strives for this goal while promoting bio-based materials and bioenergy, which are more sustainable. Germany, the UK, and France are prominent players in the industrial biotechnology area, where developments concerning healthcare sectors such as gene therapy and synthetic vaccines are becoming more prevalent.

Why is Asia-Pacific expected to grow rapidly in the synthetic biology market?

The Asia-Pacific synthetic biology market size was exhibited at USD 4.59 billion in 2025 and is predicted to surpass around USD 15.55 billion by 2035. Asia-Pacific market is expected to grow owing to the rapid expansion in the investments related to the biotechnology sector and the rising demand for the eco-friendly options. Further, countries such as China, India, and Japan are implementing agricultural, health and energy-related biotechnology and synthetic biology strategies. State administration encourages such initiatives while academic institutions enter into active cooperation with businesses, which enables the growth of the region.

India Synthetic Biology Market Trends

• Increased investment in biotechnology, bio-manufacturing, innovation, and sustainable solutions are fueling the growth of the synthetic biology market in India. Biotechnology in the country is thriving as supported by governmental programs like the BioE3, higher research spending and establishment of biotechnology hubs for advanced biological technology solutions.
• Increasing biotechnology industry in the country offers opportunities for the implementation of synthetic biology solutions across various verticals, including healthcare, agriculture, industrial biotechnology, and environmental management. 
• The healthcare segment is a dominant sector for synthetic biology in India with increasing need for gene therapy, precision medicine, vaccines and smart diagnostics. With burgeoning Indian pharmaceutical and bio-pharmaceutical companies in the country the demand for engineered biological systems, synthetic DNA and microbe produced bio-products are on the rise.
• Agricultural biotechnology is another leading growth segment for synthetic biology applications in India, owing to increased demand for environmentally friendly and sustainable farming practices. The increasing application of bio-pesticides and bio-fertilizers, production of disease resistant varieties and high yielding plants are driving demand for adoption of synthetic biology based technologies for the agricultural sector.

Synthetic Biology Market Revenue Share, By Region, 2025 (%)

What are the growth factors of LAMEA synthetic biology market?

The LAMEA synthetic biology market was valued at USD 1.29 billion in 2025 and is anticipated to reach around USD 4.39 billion by 2035. Latin America, the Middle East, and Africa (LAMEA) are areas where the relatively new field of synthetic biology is gaining ground with the primary emphasis being on biofuels and sustainable agriculture. While Brazil and Argentina have sought to enhance the agricultural biotechnology for higher crop yields, countries in the Middle East are latching onto biomaterials for renewable energy. The lack of adequate infrastructure and financing remains an impediment. However, capacity building initiatives and partnerships among nations are slowly increasing the development of the market in these regions.

Segmental Analysis

The synthetic biology market is segmented into product, technology, application, end user, and region. Based on product, the market is classified into oligonucleotide/oligo pools and synthetic DNA, chassis organism, enzymes, xeno-nucleic acids, and cloning technologies kits. Based on technology, the market is classified into NGS technology, PCR technology, genome editing technology, bioprocessing technology, microfluidics, bioinformatics, nanotechnology, and other. Based on application, the market is classified into healthcare and non-healthcare. Based on end use, the market is classified into biotechnology and pharmaceutical companies, academic and research institutes and others.

Product Analysis

Oligonucleotide/Oligo Pools and synthetic DNA: This segment has dominated the market in 2025 (35.47%). Oligonucleotide and synthetic DNA products are crucial factors in the synthetic biology market. These small deoxyribonucleotide or ribonucleotide sequences are made to order for purposes of gene therapy, diagnostic tools and even for carrying out synthetic biology experiments. Oligo pools allow for the synthesis of thousands of varying sequences at once thus promoting high throughput screening and functional genomics. Complete genes or synthetic DNA structures that may include genetic pathways are essential in the creation of modified organisms for use in Industry, Agriculture and medicine.

Enzymes: Enzymes are very important when it comes to synthetic biology and act as biocatalysts for several biochemical activities that are needed for the process. They assist in processes such as synthesis, degradation, and alteration of DNA thus enabling the precise design of various genes. Enzymes like polymerase, ligase and harmful nucleases are of great relevance in gene editing, gene cloning procedures and also in metabolic engineering activities.

Chassis Organisms: Chassis organisms are host cells that are constructed like Escherichia coli, yeast, or algae and are used in turn for the development of synthetic biology. These organelles are engineered in particular to produce certain products, where biofuels and bioplastics lie within the parenthesis of drugs and food additives. Because of their potential to accommodate synthetic pathways with the optimization of metabolic processes, they are considered the backbone of the bio-manufacturing sector.

Xeno-Nucleic Acids(XNAs): Synthetic nucleic acid for stable DNA and RNA. Xeno-nucleic acids (XNAs) are similar to natural DNA or RNA but are conformed in a manner that they are more chemically stable and do not undergo any enzymatic degradation. In contrast to the natural nucleic acid XXX, made up of stable XNAs, it is possible to use XNAs in medicines and in making Xeno that contain the XX nucleic acid structures. They are also being developed for gene therapy instead of the standard nucleic acids and for designing new biopolymers as molecular machinery.

Cloning Technologies Kits: The cloning technologies kits segment is expected to witness the fastest CAGR during the forecast period. With the onset of synthetic biology, the core methodology of adding genetic material to organizing systems has received a lot of focus and cloning technologies kits have made it possible to develop and commercialize this process with ease. This kit helps the users with the reagents, tools and protocols to design the alteration of genes and design biological apparatus ready for use. They are essential in the production of therapeutic proteins and biomaterial development technologies.

Technology Analysis

NGS Technology: Synthetic biology involves next-generation sequencing (NGS) technologies which form the basis of the control of biological functions in synthetic biology due to their ability to analyze the genomes significantly faster. It facilitates the plasmid structure sequencing as well as genomes of interest over a certain population, which includes, for instance, sequencing of metagenomes. NGS not only aids in the design of synthetic pathways and the construction of organisms but also assists in the streamlining of genetic circuits.

PCR Technology: Polymerase chain reaction (PCR) technology is one of the most significant aspects of synthetic biology since it allows the multiplication of a specified DNA sequence that can be used for various purposes. When cloning, analyzing gene expression, or producing artificial assemblages, PCR is also necessary. PCR is the technique that is utilized when high sensitivity and accuracy are needed as in genetic diagnostics and genetic manipulation with the help of; qPCR or quantitative polymerase chain reaction and digital PCR.

Bioprocessing Technology: Every innovation in synthetic biology must eventually integrate into an industrial-scale biomanufacturing system and that is where bioprocessing technologies come into play. It includes activities such as growing genetically engineered organisms and harvesting products derived from biological sources for instance biofuels, bioplastics and therapeutics. With modern bioprocessing techniques such as fermentation optimization and downstream processing, it is possible to obtain products that have high yield and purity.

Genome Editing Technology: The development of genome editing tools CRISPR-Cas9, TALENs, and ZFNs, has had a very positive impact on the field of synthetic biology in that it has become possible to modify specific sites within a genetic material. These instruments enables the scientists to edit, delete or add DNA in the creation of an organism with a specifically designed trait. Improvement of the genome editing has led to the development of the gene therapy, enhancement of crops, and enhancement of the microbial production systems.

Application Analysis

Healthcare: The application is revolutionizing the healthcare landscape with its potential in gene therapy, personalized medication, and vaccine manufacture. New genetically engineered vectors and genetic based systems are developed to treat genetic diseases, tumors, or infectious pathogens. Other techniques aimed at the treatment and prevention of a disease include CRISPR gene editing and synthetic biology applications such as targeted therapy and diagnostics development.

Synthetic Biology Market Revenue Share, By Application, 2025 (%)

Non-Healthcare: In addition to healthcare, synthetic biology is changing the game for other sectors like agriculture, energy and materials. For agriculture, this helps in developing crops through genetic means with better yield, resist pest attacks and better nutrient usage. For biobased energy, synthetic biology is the application of modified microbes for producing fuels such as biofuels than using the traditional way of fossil fuels.

Synthetic Biology Market Top Companies

• Thermo Fisher Scientific, Inc.
• Synthetic Genomics Inc.
• Synthego
• Scarab Genomics, Llc
• Pareto Bio, Inc.
• Novozymes
• New England Biolabs
• Merck Kgaa (Sigma-Aldrich Co. Llc)
• Illumina, Inc.
• Eurofins Scientific
• Enbiotix, Inc.
• Creative Enzymes
• Creative Biogene
• Codexis, Inc.
• Bota Biosciences Inc.

Recent Developments

• In 2023: The year of the new program’s announcement: functional chemicals from synthetic biology by Sumitomo Chemical Co., Ltd. and Ginkgo Bioworks based on the recent expansion of their biomanufacturing alliance.
• In 2023, NREL began a synthetic biology project with the help of LanzaTech, Northwestern and Yale University to facilitate the discovery of new biofuels. The initiative combine genome engineering and machine learning to enable the rapid development of processes for commercial, carbon-negative production of biofuels and biomarkers in a sustainable manner.

Market Segmentation

By Product

• Oligonucleotide/Oligo Pools and Synthetic DNA
• Chassis Organism
• Enzymes
• Xeno-Nucleic Acids
• Cloning Technologies Kits

By Technology

• NGS Technology
• PCR Technology
• Genome Editing Technology
• Bioprocessing Technology
• Microfluidics
• Bioinformatics
• Nanotechnology
• Other 

By Application

• Healthcare
  
  • Clinical
  • Bio/Pharmaceuticals
  • Diagnostics
  • Non-Clinical
• Non-healthcare
  
  • Biotech Crops
  • Specialty Chemicals
  • Bio-fuels
  • Others

By End Use

• Biotechnology and Pharmaceutical companies
• Academic and Research Institutes
• Others

By Region

• North America
• APAC
• Europe
• LAMEA